Welcome Guest

Sign In Register

Home
API
Manufacturing
Clinical Trials
Analytical Testing
Cold Chain

Articles
- Facility Tours
News
Events
Videos
- Clinical Trials Documentary
- A Solid Dosage Future Documentary
Whitepapers/App Notes
Issue Archives
Company Focus
Service Directory
Register
Sign In

Home
Service Directory
API
Active Pharmaceutical Ingredient (API) Products and Services
Active Pharmaceutical Ingredient (API) Manufacturing Services

Active Pharmaceutical Ingredient (API) Manufacturing Services

Your search for API returned 11 results.

Showing 20 of 20 products

<<
<
>
>>

Sort By

Get quotes for all products

Select up to 5 products from below to compare or request more information.

Get quotes Compare

Sponsored Services

Compare or Get quote for selected.

Contract API Manufacturing

Abbvie

Request Information

Compare or Get quote for selected.

API cGMP Synthesis Services

Pfanstiehl

Request Information

Compare or Get quote for selected.

API drug development and manufacturing services

Creative Biolabs Inc.

Request Information More Info

Compare or Get quote for selected.

APIs & Intermediate Active Ingredients

Fareva SA

Request Information Learn More

Compare or Get quote for selected.

Highly Potent APIs

Fareva SA

Request Information Learn More

Compare or Get quote for selected.

Sterile APIs

Fareva SA

Request Information Learn More

Compare or Get quote for selected.

API Development & Manufacturing Services

VectorB2B

Request Information Learn More

Compare or Get quote for selected.

Contract Bioconjugate Drug Substance Manufacturing

Abzena

Request Information More Info

Compare or Get quote for selected.

Contract Biologic Drug Substance Manufacturing

Abzena

Request Information More Info

Compare or Get quote for selected.

Drug substance synthesis and manufacturing

Quotient Sciences

Request Information More Info

Compare or Get quote for selected.

Contract manufacturing

GSK

Select up to 5 products from above to compare or request more information.

Get quotes Compare

Companies that sell Active Pharmaceutical Ingredient (API) Manufacturing Services

Adare Pharma Solutions

Philadelphia, PA, United States

AminoAcids.com

St. Paul, MN, United States

Ash Stevens

Riverview, MI, United States

Cambrex

East Rutherford, NJ, United States

Central Glass Germany GmbH

Halle-Kunsebeck/ Westf., Germany

Cook Pharmica

Bloomington, IN, United States

Corden Pharma International

Plankstadt, Plankstadt, Germany

Gallus BioPharmaceuticals

St. Louis, Missouri, United States

VectorB2B

Lisbon, Portugal

Tags:

Please Login or Register to Create Tags

Articles

Axplora Appoints Haitz as President of its Novasep CDMO Business Unit
Managing Risk in API Manufacturing is the Key to Successful Projects, Safer Drugs
Onyx Scientific Announces Investment in Commercial API License
Willow and Suanfarma announce collaboration on development of large volume anti-infective API through precision fermentation
WuXi’s PDS Division Merges with STA
Cambrex Invests in New Analytical Development, Method Validation Lab at High Point Facility
Grand River Aseptic Manufacturing Expands with New Colanar Syringe Filler
WuXi STA Changzhou Site Passes FDA Inspection
Three Chemists Join Arcinova’s API Department
Minafin Invests $18M to Extend Minakem’s Production Capacity in France
Cambrex Invests in New Laboratory Expansion at Sweden Facility
Sun Pharma, Samsung Biologics Announce Manufacturing Tie-Up for Tildrakizumab
SK Capital Acquires Perrigo Company’s API Business
Glenmark Enters Exclusive Agreement with Cyndea for Generic Soft-Gelatin Capsule Drug Products
Sterling Pharma Solutions Expands Presence in Japan
What Could Possibly Go Wrong in API Development?
Cambrex Expands Generic API R&D Capabilities at Milan, Italy Site
Commercial Application Segment to Dominate Global Small Molecule API Market
Hovione Announces New MG2 Capsule Filling Unit
Porton Pharma Solutions, Codexis Launch Global Partnership
FDA Alerts Drug Makers of Recall of Porcine Thyroid API from Sichuan Friendly
Potential Contribution of a Plasticized PVC Packaging Material to the Level of Elemental Impurities in Packaged Drug Products
Expect Pharmaceutical Contract Manufacturing to Continue Apace in 2016
PharmaLogic Opens Radiopharmaceutical Production Facility in Los Angeles
Hovione Expands Spray Drying Capacity Investments in the USA and Ireland
The Global Outlook for Generics, Biosimilar and API Manufacturers: Trends, Opportunities & Challenges
HORIZON LINES A Review of NDAs for January-February, 2016
Reshaping Buyer/Seller Relationships to Create More Value
Establishing Successful Non-GMP Material Supply Chains for Outsourced API Development and Manufacturing – Evolution of a Phase-Dependent Strategy
Noramco Acquires Cambrex Drug Product Business Unit
An Interview With...David Lyon, Director of Research, Capsugel’s Bend, Ore. Facility
New Requirements for Excipients...Roundtable
Johnson Matthey Acquires Pharmaceutical Manufacturing Capacity in Scotland, UK
Zealand Pharma Appoints Eric Cox as Chief Commercial Officer
NJ Bio and Charles River Partner to Advance ADC Development and Manufacturing Services
Rentschler Biopharma Appoints Global Head of Business Development
Sirio Pharma Names General Manager of Sirio Americas Business Unit
PL Developments Brings Avéma Pharma Solutions Under PLD Banner
Benuvia Operations Awarded NIH Contract for GMP Synthesis of Psilocybin and Other Bulk Drug Substances
Selecting and Continuing Relationships with API Suppliers
The Five Competencies of Continuous Regulatory Compliance
Analytical Methods and Control Strategies: The Forgotten Interface?
Considering the Standardization of Strategies for Establishing Extractables Profiles for Plastic Components Used in Drug Product Production Systems
An Interview With...Peter Pekos, President & CEO, Dalton Pharma Services
Outsourcing Your API Manufacturing to Asia? Key Things to Think About
Asymchem Opens Small Molecule Development and API Pilot Plant Manufacturing in Sandwich, Kent, UK
Evotec Sells API Manufacturing Facility
Axio BioPharma Launches Protein Manufacturing Services
What’s The Real Answer to Rising Costs of Blockbuster Drugs? Competition
National Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
Canada to Invest in Mississauga-Based Eurofins CDMO Alphora Inc.
Enhancing Responsiveness with Embedded Flexibility
Expediency vs. QbD: Resolving the Conflict in Early and Mid-Stage API Development for Virtual Pharmaceutical Companies
Trends in Enhancing API Solubility
Darmerica Recalls Quinacrine Dihydrochloride Due to Labeling Error
Lonza Upgrades Powder Characterization Capabilities at Tampa Site
Croda Builds New Excipient Manufacturing Facility in Lamar, Pennsylvania
AtkinsRéalis to Design Jubilant HollisterStier’s New Facility in Montreal, Canada
Vetter Enlists in Science-Based Targets Initiative Group for Climate Neutrality
WuXi Biologics Successfully Completes First 16,000L Manufacturing Run in Ireland
ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property
CordenPharma Signs Multi-Year Agreement for the Manufacturing of a Commercial Peptide
Wheeler Bio Closes $31 Million Series A Round Supporting its CGMP Drug Substance Manufacturing Facility in Oklahoma City
Multiply Labs and Akron Bio Collaborate to Streamline Automated Utilization of cGMP-Compliant Liquid Cytokines in Cell Therapy Manufacturing
Cambrex Nears Completion of 5-year, $100M Investment Plan, One Year Ahead of Schedule
Almac Pharma Services Announces Successful FDA Inspection at Charnwood, UK Facilities
PCI Pharma Services’ Bedford, NH Location Successfully Completes ICMRA Inspection
Changes In the Wind for the CDMO Market
The Long Paper Trail of Documentation in API Manufacturing
Solubility in Pharmaceutical R&D: Predictions and Reality
Ritedose and Newberry College Launch Pharmaceutical Manufacturing Program
WuXi STA Adds New Peptide Manufacturing Capacity and Large-Scale Continuous Purification System
The Contract Service Provider Compact
Novadoz Announces FDA Approvals of Oseltamivir, Dofetilide
Charles River Establishes eXpDNA™ Plasmid Manufacturing Platform to Expedite DNA Programs
C2 Pharma Expands Ophthalmic API Portfolio with Tropicamide Launch and Multiple Regulatory Filings
Parenteral Preparations, Challenges in Formulations
WuXi STA Shanghai, Changzhou Facilities Pass FDA Inspections
Technology Transfer Packages for Contract Manufacturing: Iterations During the Development Cycle
Coming Clean on Quality in the Chemical Manufacturing Lab
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility
Provepharm Life Solutions Obtains FDA Authorization to Produce its Active Ingredients for the United States
Farmabios, Novasep and PharmaZell are Now Axplora
Allcells Expands Apheresis Network for Cell and Gene Therapy Products and Services
FDA Releases Statement on Efforts to Improve Quality of Compounded Drugs
Active Pharmaceutical Ingredients (APIs) Roundtable
Screening and Formulating Drugs as Salts to Improve API Performance
Takeda Opens Manufacturing Plant in Ireland
Ascensus Expands Fine Chemicals Production Capabilities for Life Sciences with Acquisition of Wychem
Novasep invests €6M to Further Expand API Production Capacity at its Chasse-sur-Rhône Site
Active Pharmaceutical Ingredients Market To Reach USD 346.4 Billion By 2032
Whitepaper: How to Select the Ideal HPAPI Manufacturing Partner
Eurofins CDMO Alphora Inc. (Canada) Completes New API Manufacturing Facility
Sterling Pharma Solutions Expands HPAPI Capabilities in Germantown, WI
An Interview With Richard Castledine
Experic Strengthens Safety Measures for Highly Potent Pharmaceutical Manufacturing at NJ Facility
Novo to Acquire Catalent
Ardena’s Nanomedicine Facility Secures Full GMP Approval for Manufacturing
How to Implement a Gold Standard FSP Partnership to Maximize Quality, Efficiency and Operational Effectiveness
CluePoints Appoints Chief Product and Technology Officer
Sterling Pharma Solutions Partners with Soligenix for the Manufacture of Oncology-Targeted API
Noramco Group Invests $25M in Halo Pharma’s Facility in Whippany, NJ
Agilent Invests $725M to Expand Manufacturing Capacity for Nucleic Acid-Based Therapies

2025 Contract Services Directory and Guide

2025 Contract Services Directory and Guide
View Issue

Subscriptions

Get started here for yourcomplimentary print ordigital subscription

Get started here for your complimentary print or
digital subscription Sign up Now »

Sign up for our eNewsletter!

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Pharmaceutical Outsourcing is the leading review of business and technology for the pharmaceutical industry throughout North America.

Pharmaceutical Outsourcing 25th anniversary
A Publication of See our other sites »

Connect with Us

Copyright © 2025 CompareNetworks, Inc. All rights reserved.

About PO

About Us
Contact Us
Press Room
Privacy Policy
Disclaimer
Author Guidelines

Advertise with Us

Media Kit Request

Resources

Issue Archive
Service Directory
Clinical Trials Documentary
Solid Dosage Documentary
API
Manufacturing
Clinical Trials
Analytical Testing
Cold Chain

Subscription

Subscribe eNewsletters
Subscribe Magazine
Manage Your Print Subscription